RedChip is the world leader in investor relations, financial media, and research for microcap and small-cap stocks. Founded in 1992, and headquartered in Orlando, Florida, with affiliates in New York and Pittsburgh, RedChip has helped hundreds of companies achieve their capital markets goals. RedChip has been ranked by Inc. magazine as one of the fastest growing privately held investor relations firms in the U.S. RedChip represents 70+ emerging growth companies in a variety of industries including Biotechnology and BioPharma, Business Services, Consumer Goods, High Tech, Mining and Minerals.
Pitch Analysis
Required Pod Score for this show. PitchCentric checks your profile against host openness, topical fit, and audience signals before you generate a pitch.
Contact path
Verified email
Booking probability
34%
Guest openness
Selective
Verified email on file
80/100
Required Score
Sign up to generate a grounded pitch for Small Stocks, Big Money.
Small Stocks, Big Money is a business podcast hosted by RedChip Companies, with 155 episodes on record and a Required Pod Score of 80. PitchCentric scores this show on Booking Probability, Listen Score, and live audience signals refreshed every 24 hours.
About the host
RedChip Companies hosts Small Stocks, Big Money, a business show with 155 episodes published.
Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.
Episode #36
One Solution, Five Disease Pathways: CEO Pete O'Heeron on Fibrobiologic's (Nasdaq: FBLG) Fribroblast
Sep 15, 20267 minS4
CEO Pete O'Heeron joins RedChip to explain why FibroBiologics (Nasdaq: FBLG) believes fibroblasts, not stem cells, represent the next major platform in regenerative medicine.FibroBiologics is a clinical-stage biotech built around a simple but underappreciated fact: fibroblasts, the cell type behind Dr. Shinya Yamanaka's Nobel Prize-winning discovery of induced pluripotent stem cells, appear to be more potent and more immune-modulating than the stem cells they helped create. They also outnumber stem cells roughly 5,000 to 1 in the human body. Rather than building around a single drug candidate, as many biotech companies do, FibroBiologics has used that abundance to construct a multi-program platform spanning wound care, orthopedics, autoimmune disease, oncology, and thymus regeneration — an approach O'Heeron says has produced clinical-stage success across every therapeutic pathway the company has pursued.The company's furthest-along program targets diabetic foot ulcers, where O'Heeron says fibroblasts do what they do best: heal wounds. It's a 12-week trial designed to validate in the clinic what has been shown in animal studies, healing time cut in half compared to a leading wound-care product from Smith & Nephew. That program sits alongside a broader pipeline spanning autoimmune disease, orthopedics, oncology, and thymus regeneration. The company says it has seen clinical success on every therapeutic pathway it has pursued so far. Its intellectual property position underpins that breadth: more than 250 patents issued and pending, covering therapeutic use of fibroblasts. FibroBiologics is a client of RedChip. To learn more about FBLG and to read our full disclosure, visit: https://www.FBLGinfo.com#FBLG #FibroBiologics #Fibroblasts #CellTherapy #RegenerativeMedicine #StemCellAlternative #DiabeticFootUlcers #MultipleSclerosis #WoundCare #Biotech #SmallCapStocks #Nasdaq #InvestorEducation #StockInterviews
Autonomous Navigation in GPS-Denied Environments | CEO Ben Williams on Exyn Technologies (EXYN)
Sep 8, 20267 minS4
Ben Williams, CEO and COO of Exyn Technologies (Nasdaq: EXYN), explains how the company's ExynAI platform solves one of robotics' hardest problems: navigating and mapping in places where GPS simply doesn't work.Exyn is an autonomous robotics and geospatial intelligence company built on its proprietary Level 4B autonomy platform, which enables drones and robots to navigate, map, and collect survey-grade data without GPS, communications links, prior maps, or external infrastructure — what the company calls "infrastructureless autonomy." That capability is critical underground, below tree canopy, indoors, and in contested defense environments, positioning Exyn across a combined addressable market exceeding $70 billion in mining, infrastructure, construction, geospatial, and defense.The technology has been commercially proven for six years, with external users completing over 1,000 autonomous missions monthly. The company is now transitioning toward a scalable software model through its ExynAI SDK, enabling OEM and third-party licensing, while its Range subsidiary pursues defense and government contracts. Ben also discusses Exyn's green UAS certification process for Nexus — a step toward larger U.S. government and defense procurement — and how the company's self-contained autonomy lets it expand into new industries and environments without additional infrastructure or training. Exyn Technologies is a client of RedChip. To learn more about EXYN and to read our full disclosure, visit: EXYNinfo.com#EXYN #ExynTechnologies #AutonomousRobotics #DroneStocks #DefenseTech #ISR #GeospatialIntelligence #Nasdaq
8 Products, One Ore Body, $560/Ton Margin: CEO Mark Smith on NioCorp's Updated Feasibility Study
Sep 1, 20268 minS4
CEO Mark Smith joins RedChip to break down NioCorp's (Nasdaq: NB) newly updated Elk Creek feasibility study and the company's expanding role in U.S. critical minerals supply.NioCorp Developments is advancing the Elk Creek Critical Minerals Project in Nebraska, a domestic source of niobium, scandium, titanium, and magnetic rare earth elements the U.S. currently imports at rates Smith details in the interview. As Smith explains, the updated feasibility study reflects "a tremendous amount of work" on metallurgy, with the project now positioned to produce eight distinct products from a single ore body — what he calls "a risk mitigation device for a mining company" rarely seen in the industry.The additional product streams translate directly to economics: Smith states the margin on the ore body is about $560 per ton of ore, against a mine plan of roughly one million tons of ore per year. On the scandium side, Smith discusses NioCorp's work with the Department of War, including the $10 million grant received in August 2025, and a newly announced non-binding memorandum of understanding with Lockheed Martin for the potential purchase of "up to 15 tons per year of scandium" from the Elk Creek operation. Smith also references the company's ongoing weekly discussions with the U.S. Export-Import Bank as it works toward financing to reach construction.Smith closes by describing scandium as one of the more overlooked pieces of NioCorp's portfolio today, but one he expects to become "one of the flashier pieces of our project" as the defense and aerospace applications gain traction. NioCorp holds locked-in offtake agreements covering 75% of planned niobium output with Thyssenkrupp and Traxys North America, alongside the largest scandium sales deal on record with Traxys. NioCorp Developments (NB) is a client of RedChip. To learn more about NB and to read our full disclosure, visit: redchip.com/stocks/NB#NB #NioCorp #CriticalMinerals #RareEarths #Scandium #Niobium #Nasdaq #SmallCapStocks #MicroCapStocks #DefenseStocks #NationalSecurity #MiningStocks #InvestorEducation #StockInterviews
Tokenizing Wall Street: David Wachsman on Hawkeye Digital (OTC: HWKE)
Aug 25, 20269 minS4
Visit RedChip.com to learn David Wachsman, President of Hawkeye Digital, Inc. (OTC: HWKE), joins RedChip to break down a new platform built to bridge Wall Street and the digital asset industry.Hawkeye is building an integrated merchant banking and private equity platform focused on the institutionalization of digital assets. Rather than depending on token price swings, the Company earns advisory fees and minority stakes through merchant banking engagements, while its private equity arm acquires majority stakes in mature, cash-flow generating crypto businesses. Wachsman, who founded blockchain communications firm Wachsman in 2015, brings over a decade of advisory relationships across the industry's leading players to source proprietary deal flow that traditional PE firms and investment banks can't easily replicate.In the interview, Wachsman outlines Hawkeye's two business lines, the type of acquisition targets the Company looks for (established, cash-generating businesses with product-market fit rather than early-stage startups), and the opportunity he sees in the tokenization of real-world assets as Wall Street shifts to blockchain rails. He also discusses Hawkeye's leadership team, pairing his deal-sourcing network with decades of capital markets experience from co-founder Marty Sumichrast and the board.Hawkeye is executing a path toward a national exchange uplisting, backed by ThinkEquity as financial advisor, aiming to expand investor awareness, trading liquidity, and institutional ownership as the Company builds its portfolio. Hawkeye Digital is a client of RedChip. To learn more about HWKE and to read our full disclosure, visit: redchip.com/stocks/HWKE#HWKE #HawkeyeDigital #DigitalAssets #Crypto #Blockchain #MerchantBanking #PrivateEquity #Tokenization #SmallCapStocks #MicroCapStocks #OTCStocks #InvestorEducation #StockInterviews #CryptoStocksmore.
This week's episode of Small Stocks Big Money features exclusive interviews with senior executives from Virax Biolabs Group (NASDAQ: VRAX) & TransCode Therapeutics (NASDAQ: RNAZ)Explore the latest insights and updates in the world of small-cap stocks.Visit RedChip.com to learn more.
Every question we get asked before someone starts their trial.
If you have a concern about deliverability, AI quality, data privacy, or whether this will actually work for your specific situation, it's probably answered below.
What is the difference between Founder Solo and Founder Pro?
Founder Solo gives you 50 AI pitches per month using the credit model (Standard pitches cost 1 credit, Enriched pitches cost 2). Founder Pro raises that to 200 credits per month and adds full Booking Probability access, unlimited Magic Match, Apollo enrichment credits, and data export capabilities. Both plans use the same credit system, so you can stretch your monthly budget further by using Standard-mode drafting.
How do agency tiers work?
Agency tiers have no base fee. You pay per managed client and per talent profile. Agency Standard is $199 per client per month; Agency Pro is $399 per client per month. Both add $39 per talent profile per month. Your own team's user seats are always free.
What is a talent profile?
A talent profile represents one person (founder, executive, or spokesperson) you are booking onto podcasts. It includes their bio, topics, headshots, and outreach history. Team plans include 5 profiles; agency plans are pay-as-you-go.
Can I switch plans later?
Yes, at any time. Upgrades take effect immediately; downgrades apply at the end of the current billing period. Contact support if you need help migrating between plan families.
Do you offer a free trial?
Every paid plan includes a 15-day free trial. Your card is saved at signup but you will not be charged until day 16. Cancel any time from your dashboard.
What happens if I cancel?
You keep access until the end of your current billing period. No charges after that. Your data is retained for 30 days in case you reactivate.
Is the 20% annual discount automatic?
Yes. Select Annual on the pricing toggle and the discounted price is applied automatically at checkout. The annual price shown is the full year cost.
What if I have more than 50 profiles or 20 clients?
That is our Enterprise tier. Contact our sales team and we will build a custom plan with volume pricing, a dedicated account manager, and SLA guarantees.
